Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Gundert-Remy

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
European Journal of Clinical Pharmacology|January 1, 1982
Elimination of azlocillin in patients with biliary t-tube drainageU Gundert-Remy, E Weber
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Lack of pharmacological active saliva levels of caffeine in breast-fed infantsR Hildebrandt, U Gundert-Remy
European Journal of Clinical Pharmacology|December 1, 1973
Determination of nanogram quantities of diphenhydramine and orphenadrine in human plasma using gas-liquid chromatographyW Bilzer, U Gundert-Remy
Arzneimittel-Forschung|July 1, 1975
[Biological availability]E Weber, U Gundert-Remy
Journal of Chromatography|March 12, 1982
Improved procedure for the determination of the ureidopenicillins azlocillin and mezlocillin plasma by high-performance liquid chromatographyR Hildebrandt, U Gundert-Remy
ZFA. Zeitschrift Fur Allgemeinmedizin|January 20, 1978
[Drug use in practice. Illusion and reality]E Weber, U Gundert-Remy
Arzneimittel-Forschung|January 1, 1981
[Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)]U Gundert-Remy, E Weber
British Journal of Clinical Pharmacology|November 1, 1983
Binding of theophylline and its metabolites to human plasma proteinsU Gundert-Remy, R Hildebrandt
Drug Safety|July 1, 1994
Bioinequivalence and drug toxicity. How great is the problem and what can be done?C H Gleiter, U Gundert-Remy
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
The regulatory view on drug-drug interactionsH J Müller, U Gundert-Remy
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
European Journal of Clinical Pharmacology|January 1, 1982
Elimination of azlocillin in patients with biliary t-tube drainageU Gundert-Remy, E Weber
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Lack of pharmacological active saliva levels of caffeine in breast-fed infantsR Hildebrandt, U Gundert-Remy
European Journal of Clinical Pharmacology|December 1, 1973
Determination of nanogram quantities of diphenhydramine and orphenadrine in human plasma using gas-liquid chromatographyW Bilzer, U Gundert-Remy
Arzneimittel-Forschung|July 1, 1975
[Biological availability]E Weber, U Gundert-Remy
Journal of Chromatography|March 12, 1982
Improved procedure for the determination of the ureidopenicillins azlocillin and mezlocillin plasma by high-performance liquid chromatographyR Hildebrandt, U Gundert-Remy
ZFA. Zeitschrift Fur Allgemeinmedizin|January 20, 1978
[Drug use in practice. Illusion and reality]E Weber, U Gundert-Remy
Arzneimittel-Forschung|January 1, 1981
[Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)]U Gundert-Remy, E Weber
British Journal of Clinical Pharmacology|November 1, 1983
Binding of theophylline and its metabolites to human plasma proteinsU Gundert-Remy, R Hildebrandt
Drug Safety|July 1, 1994
Bioinequivalence and drug toxicity. How great is the problem and what can be done?C H Gleiter, U Gundert-Remy
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1994
The regulatory view on drug-drug interactionsH J Müller, U Gundert-Remy
Pageof 13